• Date: 2025
  Title: Non-amyloid specific treatment for transthyretin cardiac amyloidosis: a clinical consensus statement of the ESC Heart Failure Association
• Date: 2025
  Title: Future development of arrhythmogenic risk scores in patients with heart failure and inherited dilated cardiomyopathy. A scientific statement of the Heart Failure Association of the ESC
• Date: 2025
  Title: SGLT2 inhibitors for the prevention and treatment of heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the Heart Failure Association of India (HFAI)
• Date: 2025
  Title: Management of aortic stenosis and chronic heart failure. A scientific statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC
• Date: 2025
  Title: Heart failure with preserved ejection fraction in cancer patients and survivors. A Scientific Statement of the Heart Failure Association of the ESC and the ESC Council of Cardio-Oncology
• Date: 2025
  Title: Prevention of cancer therapy-related cardiac dysfunction and heart failure in cancer patients and survivors
• Date: 2025
  Title: Vaccination as a new form of cardiovascular prevention
• Date: 2025
  Title: The crosstalk between immune activation and metabolism in heart failure. A scientific statement of the Heart Failure Association of the ESC
• Date: 2025
  Title: Heat extremes and cardiovascular diseases
• Date: 2025
  Title: The Use of Left Ventricular Ejection Fraction in the Diagnosis and Management of Heart Failure. A Clinical Consensus Statement of Heart failure Association of the European Society of Cardiology (HFA), Heart failure of America (HFSA), Japanese Heart Failure Society (JHFS)
• Date: 2025
  Title: Cardiac implantable electronic and other monitoring devices in continuous-flow left ventricular assist device patients. A clinical consensus statement of the Heart Failure Association and the European Heart Rhythm Association of the ESC
• Date: 2025
  Title: How to handle polypharmacy in heart failure. A Clinical Consensus Statement from the Heart Failure Association of the ESC
• Date: 2025
  Title: Update on Preclinical Models of Cancer Therapy-Related Cardiac Dysfunction: Challenges and Perspectives. A scientific statement of the Heart Failure Association (HFA) of the ESC, the ESC Council of Cardio-oncology and the ESC Working Group on Cellular Biology of the Heart
• Date: 2025
  Title: Implementation of guideline directed medical therapy in low blood pressure heart Failure with reduced ejection fraction. A Clinical Consensus Statement of the Heart Failure Association of the ESC
• Date: 2025
  Title: Examining the role and preparation of heart failure nurses across Europe. A survey of the Heart Failure Association (HFA) of the ESC and the Association of Cardiovascular Nursing & Allied Professions (ACNAP) of the ESC
• Date: 2024
  Title: State of the art and perspectives of gene therapy in heart failure. A scientific statement of the Heart Failure Association of the ESC, the ESC Council on Cardiovascular Genomics and the ESC Working Group on Myocardial & Pericardial Diseases
• Date: 2024
  Title: Examining the clinical role and educational preparation of heart failure nurses across Europe
• Date: 2024
  Title: Awareness, access, and adoption of natriuretic peptides for diagnosis of heart failure
• Date: 2024
  Title: Digital solutions to optimize guideline-directed medical therapy prescription rates in patients with heart failure: a clinical consensus statement from the ESC Working Group on e-Cardiology, the Heart Failure Association of the European Society of Cardiology, the Association of Cardiovascular Nursing & Allied Professions of the European Society of Cardiology, the ESC Digital Health Committee, the ESC Council of Cardio-Oncology, and the ESC Patient Forum
• Date: 2024
  Title: The right heart in patients with cancer. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology
• Date: 2024
  Title: Living with peripartum cardiomyopathy: A statement from the Heart Failure Association and the Association of Cardiovascular Nursing and Allied Professions of the European Society of Cardiology
• Date: 2024
  Title: Cardiovascular toxicities of immune therapies for cancer – a scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology
• Date: 2024
  Title: European Society of Cardiology quality indicators update for the care and outcomes of adults with heart failure. The Heart Failure Association of the ESC
• Date: 2024
  Title: Management of cardiac sarcoidosis: A clinical consensus statement of the Heart Failure Association, the European Association of Cardiovascular Imaging, the ESC Working Group on Myocardial & Pericardial Diseases, and the European Heart Rhythm Association of the ESC
• Date: 2024
  Title: Diabetic myocardial disorder. A clinical consensus statement of the Heart Failure Association of the ESC and the ESC Working Group on Myocardial & Pericardial Diseases
• Date: 2024
  Title: Prevention and rehabilitation after heart transplantation
• Date: 2024
  Title: Right heart failure with left ventricular assist devices: Preoperative, perioperative and postoperative management strategies. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC
• Date: 2024
  Title: Differences in presentation, diagnosis and management of heart failure in women. A scientific statement of the Heart Failure Association of the ESC
• Date: 2024
  Title: Multi-disciplinary care of peripartum heart failure - a Scientific Statement of the Heart Failure Association of the ESC.
• Date: 2024
  Title: A roadmap for therapeutic discovery in pulmonary hypertension due to heart failure (PH-HF). A scientific statement from the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Pulmonary Circulation & Right Ventricular Function
• Date: 2024
  Title: Sodium and water intake in heart failure: a Clinical Consensus Statement of the Heart Failure Association of the ESC.
• Date: 2024
  Title: Physician perceptions, attitudes, and strategies towards implementing guideline-directed medical therapy in heart failure with reduced ejection fraction. A survey of the Heart Failure Association of the ESC and the ESC Council for Cardiology Practice
• Date: 2024
  Title: Management of cardiac emergencies in women
• Date: 2024
  Title: Integration of Implantable Device Therapy in Patients With Heart Failure. A consensus statement from the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the ESC.
• Date: 2023
  Title: Epidemiology, Pathophysiology, Diagnosis and Management of Chronic Right-Sided Heart Failure and Tricuspid Regurgitation: a clinical consensus statement by the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC.
• Date: 2023
  Title: Interaction of Heart Failure and Stroke: a Clinical Consensus Statement of the Council on Stroke, the Heart Failure Association (HFA) and the Working Group on Thrombosis of the ESC.
• Date: 2023
  Title: Practical Algorithms for Early Diagnosis of Heart Failure and Heart Stress using NT-proBNP: A Scientific Consensus Document of the Heart Failure Association of the ESC.
• Date: 2023
  Title: Competency-based cardiac imaging for patient-centred care. A statement of the European Society of Cardiology (ESC).
• Date: 2023
  Title: Placing patient-reported outcomes at the centre of cardiovascular clinical practice: implications for quality of care and management
• Date: 2023
  Title: Diagnosis and Management of Patients with Left Ventricular Hypertrophy: Role of Multimodality Cardiac Imaging. A Scientific Statement of the Heart Failure Association of the ESC
• Date: 2023
  Title: Culture, ethnicity and socio-economic status as determinants of the management of patients with advanced heart failure and need palliative care: A Clinical Consensus Statement from the Heart Failure Association (HFA) of the ESC, the ESC Patient Forum, and the European Association of Palliative Care.
• Date: 2023
  Title: Heart Failure Diagnosis in the General Community: Who, How and When: a scientific statement of the Heart Failure Association (HFA) of the ESC
• Date: 2023
  Title: Acute Heart Failure and Valvular Heart Disease: a joint scientific statement of Heart Failure Association (HFA), the Association for Acute Cardiovascular Care (ACVC) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC.
• Date: 2023
  Title: Patient Phenotype Profiling in Heart Failure with Preserved Ejection Fraction to Guide Therapeutic Decision Making. A Joint Scientific Statement of the Heart Failure Association (HFA) and the European Heart Rhythm Association (EHRA) of ESC & of the European Hypertension Society (ESH).
• Date: 2023
  Title: Pre-discharge and early post-discharge management of patients hospitalized for acute heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC
• Date: 2023
  Title: Worsening heart failure in clinical practice. A scientific statement of the Heart Failure Association (HFA) of the ESC
• Date: 2023
  Title: Natriuretic peptides: Role in the diagnosis and management of heart failure. A Scientific Statement of the Heart Failure Association (HFA) of the ESC, the Japanese Heart Failure Society, and the Heart Failure Society of America.
• Date: 2023
  Title: Inotropic therapy in chronic heart failure. A clinical consensus statement from the Heart Failure Association of the ESC
• Date: 2022
  Title: Biomarkers in Clinical Trials in Heart Failure- Position paper of the HFA of the ESC
• Date: 2022
  Title: Myocarditis Following COVID-19 Vaccine: Incidence, Presentation, Diagnosis, Pathophysiology, Therapy, and Outcomes put into Perspective. Clinical Consensus Document supported by the Heart Failure Association of the ESC and the ESC Working Group on Myocardial and Pericardial Disease
• Date: 2022
  Title: Circulating and non-circulating biomarkers in congestion- Position paper of the HFA of the ESC
• Date: 2022
  Title: Exercise Testing in HFpEF: an Appraisal Through Diagnosis, Pathophysiology and Therapy. A Clinical Consensus Statement of the Heart Failure Association (HFA) and European Association of Preventive Cardiology (EAPC) of the European Society of Cardiology (ESC)
• Date: 2022
  Title: Cardiac remodelling – Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology
• Date: 2022
  Title: Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology
• Date: 2020
  Title: Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio‐Oncology Study Group of the Heart Failure Association and the Cardio‐Oncology Council of the European Society of Cardiology
• Date: 2020
  Title: Self‐care of heart failure patients: practical management recommendations from the Heart Failure Association of the European Society of Cardiology
• Date: 2020
  Title: Integration of a palliative approach into heart failure care
• Date: 2020
  Title: Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies
• Date: 2020
  Title: Sodium–glucose co‐transporter 2 inhibitors in heart failure: beyond glycaemic control
• Date: 2020
  Title: Epidemiology, Pathophysiology and Contemporary Management of Cardiogenic Shock
• Date: 2020
  Title: Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies
• Date: 2020
  Title: Evaluation of kidney function throughout the heart failure trajectory
• Date: 2019
  Title: Sex‐ and age‐related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long‐Term Registry
• Date: 2019
  Title: The role and safety of new glucose‐lowering drugs in patients with heart failure
• Date: 2019
  Title: Imaging in patients with suspected acute heart failure
• Date: 2019
  Title: Brachial pulse pressure in acute heart failure
• Date: 2019
  Title: Frailty in patients with heart failure
• Date: 2019
  Title: How to diagnose heart failure with preserved ejection fraction
• Date: 2019
  Title: Regional differences in exercise training implementation in heart failure
• Date: 2019
  Title: Pathophysiology, diagnosis and management of peripartum cardiomyopathy
• Date: 2019
  Title: Practical guidance on the use of natriuretic peptide concentrations
• Date: 2019
  Title: Reporting checklist for quantification of pulmonary congestion by lung ultrasound in heart failure
• Date: 2019
  Title: Sacubitril/valsartan eligibility and outcomes in the ESC‐EORP‐HFA Heart Failure Long‐Term Registry
• Date: 2019
  Title: Clinical practice update on heart failure 2019
• Date: 2019
  Title: Acute heart failure congestion and perfusion status – impact of the clinical classification on in‐hospital and long‐term outcomes
• Date: 2019
  Title: Heart failure in cardiomyopathies
• Date: 2019
  Title: The role of ventricular–arterial coupling in cardiac disease and heart failure: assessment, clinical implications and therapeutic interventions
• Date: 2019
  Title: Towards better definition, quantification and treatment of fibrosis in heart failure
• Date: 2019
  Title: The use of diuretics in heart failure with congestion
• Date: 2018
  Title: Innovative imaging methods in heart failure: a shifting paradigm in cardiac assessment
• Date: 2018
  Title: Exercise training in patients with ventricular assist devices: a review of the evidence and practical advice
• Date: 2018
  Title: Afib in HF EORP
• Date: 2018
  Title: Heart failure and diabetes: metabolic alterations and therapeutic interventions
• Date: 2018
  Title: Treatments targeting inotropy
• Date: 2018
  Title: Advanced HF
• Date: 2018
  Title: Long‐term prognosis, subsequent pregnancy, contraception and overall management of peripartum cardiomyopathy
• Date: 2018
  Title: Type 2 diabetes mellitus and heart failure
• Date: 2018
  Title: An integrative translational approach to study heart failure with preserved ejection fraction
• Date: 2018
  Title: Long-term safety of intravenous cardiovascular agents in acute heart failure
• Date: 2018
  Title: Cancer diagnosis in patients with heart failure: epidemiology, clinical implications and gaps in knowledge
• Date: 2018
  Title: Characteristics, treatments and 1-year prognosis of hospitalized and ambulatory heart failure patients with chronic obstructive pulmonary disease
• Date: 2017
  Title: Heart and brain interaction in patients with heart failure: overview and proposal for a taxonomy
• Date: 2017
  Title: Indications and practical approach to non-invasive ventilation in acute heart failure
• Date: 2017
  Title: Clinical phenotypes and outcome of patients hospitalized for acute heart failure
• Date: 2017
  Title: Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management
• Date: 2017
  Title: The autonomic nervous system as a therapeutic target in heart failure
• Date: 2017
  Title: Clinical characteristics of patients from the worldwide registry on peripartum cardiomyopathy (PPCM)
• Date: 2017
  Title: Role of cardiopulmonary exercise testing in clinical stratification in heart failure
• Date: 2017
  Title: Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management
• Date: 2016
  Title: Cancer treatments and cardiovascular toxicity
• Date: 2016
  Title: Current management of patients with severe acute peripartum cardiomyopathy
• Date: 2016
  Title: Contemporary management of acute right ventricular failure
• Date: 2016
  Title: Treatment of heart failure in adult congenital heart disease
• Date: 2015
  Title: Current state of knowledge on Takotsubo syndrome
• Date: 2015
  Title: Arrhythmias in heart failure
• Date: 2015
  Title: Recommendations on pre-hospital & hospital management of acute heart failure
• Date: 2015
  Title: Cardiac Oncology Toxicity Registry in breast cancer patients: rationale, study design, and methodology (EACVI/HFACOT Registry)
• Date: 2014
  Title: Cardiovascular side effects of cancer therapies
• Date: 2014
  Title: Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy
• Date: 2013
  Title: New devices in heart failure
• Date: 2012
  Title: EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management